TYP 5.26% 2.0¢ tryptamine therapeutics limited

Ann: Independent Plexaris and Cevaris testing, page-4

  1. sle
    10,784 Posts.
    lightbulb Created with Sketch. 345
    Well certainly the newsflow for 2020 has started with a bang!! I'd be interested to see whom we may end up partnering with before year's end and at what tantalizing price???

    Exopharm is now a clinical stage company and the first company in the world to test
    a proprietary exosome product in human clinical trials for regenerative medicine
    • 2020 set to be a year of inflexion points with newsflow, partnering activity and
    clinical trials
    • Seeking to build significant shareholder value
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.001(5.26%)
Mkt cap ! $21.78M
Open High Low Value Volume
1.9¢ 2.0¢ 1.9¢ $15.61K 781.1K

Buyers (Bids)

No. Vol. Price($)
6 337830 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 275000 2
View Market Depth
Last trade - 13.07pm 16/08/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.